Cargando…

COVID-19 y hemorragia cerebral

COVID-19 is the disease caused by a new coronavirus originated in Wuhan (Hubei province in China) in December 2019, called SARS-CoV-2. It is currently responsible for a global pandemic declared on March 11, 2020 by the World Health Organization (WHO). Taking into account that patients with severe CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Cercas-Lobo, Silvia, Deniel-Rosanas, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier España, S.L.U. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751377/
http://dx.doi.org/10.1016/j.appr.2020.100078
Descripción
Sumario:COVID-19 is the disease caused by a new coronavirus originated in Wuhan (Hubei province in China) in December 2019, called SARS-CoV-2. It is currently responsible for a global pandemic declared on March 11, 2020 by the World Health Organization (WHO). Taking into account that patients with severe COVID-19 are more likely to suffer neurological symptoms, we expose a case of a hypertensive patient who has been found unconscious in the public thoroughfare. He presented right cerebellar intraparenchymal hematoma with an arteriovenous malformation and smear nasopharyngeal test positive for SARS-CoV-2. The case that we present creates the dilemma of whether the clinical picture presented by the patient is chance or causality. The SARS-CoV-2 infection could have contributed to brain hemorrhage since the new coronavirus affects the neurological system and high blood pressure is considered a risk factor for the severe evolution of COVID-19. Several cases with COVID-19 complicated by intracranial hemorrhages have been described; however, it will be necessary to carry out relevant studies to confirm this association.